Core Scientific Company Insiders
| CORZZ Stock | 19.76 0.88 4.66% |
Core Scientific employs about 325 people. The company is managed by 27 executives with a total tenure of roughly 759 years, averaging almost 28.0 years of service per executive, having 12.04 employees per reported executive. Break down of Core Scientific's management performance can provide insight into the company performance.
Core Scientific Management Team Effectiveness
The company has return on total asset (ROA) of (0.0606) % which means that it has lost $0.0606 on every $100 spent on assets. This is way below average. Core Scientific's management efficiency ratios could be used to measure how well Core Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Some institutional investors establish a significant position in stocks such as Core Scientific in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Core Scientific, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Core Scientific Workforce Comparison
Core Scientific Tranche is number one stock in number of employees category among its peers. The total workforce of Software - Infrastructure industry is currently estimated at about 27,680. Core Scientific claims roughly 325 in number of employees contributing just under 2% to equities listed under Software - Infrastructure industry.
The company has Profit Margin (PM) of (2.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6. Core Scientific Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Core Scientific insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Scientific Notable Stakeholders
A Core Scientific stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Core Scientific often face trade-offs trying to please all of them. Core Scientific's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Core Scientific's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Adam Sullivan | President CEO | Profile | |
| Denise Sterling | Executive CFO | Profile | |
| Denise CPA | Executive CFO | Profile | |
| James Nygaard | Executive CFO | Profile | |
| James Cleveland | Chief Officer | Profile | |
| Michael Bros | Executive Strategy | Profile | |
| Darin Feinstein | Co Strategy | Profile | |
| Jay Brummett | Senior Construction | Profile | |
| Russell Cann | Executive Services | Profile | |
| Todd DuChene | Chief Officer | Profile | |
| Jeff Taylor | Senior Officer | Profile | |
| Jeff Pratt | Senior Partnerships | Profile | |
| Sean Kimble | Chief Officer | Profile | |
| Jonathan Charbonneau | Vice Relations | Profile | |
| Cline Kezar | Head Operations | Profile | |
| Larry Kom | Chief Officer | Profile | |
| Carol Haines | Head Policy | Profile | |
| Rob Hepler | Head Operations | Profile | |
| Matt Tyndall | Head Development | Profile | |
| Matt Brown | Chief Officer | Profile | |
| Steven Gitlin | Senior Relations | Profile | |
| Lynn Burgener | Senior Trade | Profile | |
| Aaron Mccreery | Executive Operations | Profile | |
| Todd JD | Chief Secretary | Profile | |
| Sangeeta Puri | Vice Operations | Profile | |
| Sharon Orlopp | Chief Officer | Profile | |
| Scott Brueggeman | Chief Officer | Profile |
About Core Scientific Management Performance
The success or failure of an entity such as Core Scientific Tranche often depends on how effective the management is. Core Scientific management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Core management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Core management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Core Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Scientific Tranche. Check Core Scientific's Beneish M Score to see the likelihood of Core Scientific's management manipulating its earnings.
Core Scientific Workforce Analysis
Traditionally, organizations such as Core Scientific use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Core Scientific within its industry.Core Scientific Manpower Efficiency
Return on Core Scientific Manpower
| Revenue Per Employee | 1.6M | |
| Revenue Per Executive | 18.9M | |
| Net Loss Per Employee | 4M | |
| Net Loss Per Executive | 48.7M | |
| Working Capital Per Employee | 2.4M | |
| Working Capital Per Executive | 28.5M |
Additional Tools for Core Stock Analysis
When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.